| Date | Name | Shares | Transaction | Value |
|
Mar 9, 2026
| Hope M. Jarkowski Chief Legal Officer |
20,872
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Timothy C. Gokey CEO |
170,667
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Trish Mosconi Director |
430
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Thomas Patrick Carey Corporate VP |
25,977
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Ashima Ghei Interim CFO |
23,254
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Trish Mosconi Director |
1,786
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Douglas Richard DeSchutter Co-President ICS |
25,977
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Richard J. Stingi Corporate VP and CHRO |
10,039
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 9, 2026
| Christopher J. Perry President; Director |
51,047
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 4, 2026
| Robert N. Duelks Director |
17,000
| Bona fide gift |
0.00
|
|
Mar 4, 2026
| Robert N. Duelks Director |
N/A
| Bona fide gift |
0.00
|
|
Dec 5, 2025
| Thomas Patrick Carey Corporate VP |
15,090
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $229.26 per share |
3,459,533.40
|
|
Dec 5, 2025
| Thomas Patrick Carey Corporate VP |
16,240
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $93.88 per share |
1,524,611.20
|
|
Dec 5, 2025
| Thomas Patrick Carey Corporate VP |
8,548
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Dec 5, 2025
| Thomas Patrick Carey Corporate VP |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Dec 5, 2025
| Thomas Patrick Carey Corporate VP |
11,574
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $229.26 per share |
2,653,455.24
|
|
Dec 5, 2025
| Thomas Patrick Carey Corporate VP |
6,026
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $229.26 per share |
1,381,520.76
|
|
Nov 18, 2025
| Annette L. Nazareth Director |
8,987
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Nov 18, 2025
| Melvin L. Flowers Director |
1,758
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Nov 18, 2025
| Melvin L. Flowers Director |
2,649
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|